15th Annual American Conference on Pharmacometrics (ACoP 2024)
Nov 10 - Nov 13, 2024
Title: Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Patients with Severe Hypertriglyceridemia
Presenter: Jack Shi
Session: Poster
Title: Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Atherosclerotic Cardiovascular Disease (ASCVD) in Patients with Mixed Hyperlipidemia
Presenter: Jack Shi
Session: Poster
Supporting Materials
ACoP 2024 Ploz ASCVD 693.3 KB
ACoP 2024 Ploz SHTG 688 KB